Alto Neuroscience, Inc. (ANRO)
US$ 3.55-10.13%
Price Chart
Key Statistics
Market Cap
$ 63.62M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
561.89K
52W High
$ 17.55
52W Low
$ 1.60
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
2.6956
200-Day MA
6.8256
52 Week High
17.55
52 Week Low
1.6
About ANRO
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States.
Employees
76
Headquarters
Mountain View, CA
CEO
Dr. Amit Etkin M.D., Ph.D.
Latest News
Press Release Distribution & PR Platform - ACCESS Newswire
2 days ago • Google News
HC Wainwright & Co. Initiates Coverage of Alto Neuroscience (ANRO) with Buy Recommendation - Nasdaq
3 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg